	US 12,203,085 B2
	3'UTR sequence for transgene expression
Sandeep Kumar, Johnston, IA (US); Sara Bennett, Indianapolis, IN (US); Andrew J. Bowling, Indianapolis, IN (US); Alicia Walker, Indianapolis, IN (US); Cory M. Larsen, Zionsville, IN (US); Heather Pence, Indianapolis, IN (US); Staci Weaver, Indianapolis, IN (US); and Ronnie Hampton, Jr., Indianapolis, IN (US)
Assigned to CORTEVA AGRISCIENCE, LLC, , IN (US)
Filed by Corteva Agriscience LLC, Indianapolis, IN (US)
Filed on Dec. 15, 2021, as Appl. No. 17/551,455.
Application 17/551,455 is a continuation of application No. 16/139,112, filed on Sep. 24, 2018, granted, now 11,236,350.
Claims priority of provisional application 62/567,836, filed on Oct. 4, 2017.
Prior Publication US 2022/0098606 A1, Mar. 31, 2022
Int. Cl. C12N 15/82 (2006.01); A01H 6/60 (2018.01)

CPC C12N 15/8233 (2013.01) [A01H 6/604 (2018.05)]

9 Claims

1. A nucleic acid vector comprising a 3′ UTR operably linked to: a) a heterologous polylinker sequence; or b) a non-Glycine max egg cell polynucleotide sequence, wherein said 3′ UTR comprises a polynucleotide sequence that has at least 97% sequence identity with SEQ ID NO:3.